Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS)
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
Patients with renal lesions suspicious for renal cell carcinoma (RCC) have a variety of
different treatment pathways available to them. Imaging surveillance is being used frequently
on smaller renal masses, and radiologists are being asked to biopsy more renal lesions to
better guide decision making by urology. This is in large part due to the pathologic grade of
renal masses having been shown to correlate with patient outcomes. The World Health
Organization (WHO) or Fuhrman grade is the standard grading scale used by pathologists for
RCC. The goal of this study will be to correlate contrast enhanced ultrasound findings with
the pathologic grade of RCC. Specifically, the investigators hypothesize that tumors with
different pathologic grades will show different patterns of qualitative enhancement, as well
as different perfusion kinetics.